Genetic Testing for Opioid Use Disorder Heads to FDA Advisors https://www.medpagetoday.com/painmanagement/opioids/101314 To date, no FDA-cleared or approved devices are indicated for identifying genetic risk of OUD On Thursday, members of the FDA’s Clinical Chemistry and Clinical Toxicology Devices Advisory Committee will meet to discuss AvertD, a prescription genetic risk assessment tool for opioid use disorder […]
Filed under: General Problems | 3 Comments »